Home › Kanser (lahat ng uri) › Virginia › Arlington
Pag-aaral pangklinika para sa Kanser (lahat ng uri) sa Arlington, VA
Isang pag-aaral para sa Kanser (lahat ng uri) ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Arlington. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Nagre-recruitPhase 3
- Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Nagre-recruitPhase 2/3
- Virginia Cancer Specialists - Fairfax /ID# 275071, Fairfax · 11 mi ang layo
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Nagre-recruitPhase 1/2
- NEXT Virginia, Fairfax · 11 mi ang layo
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
Nagre-recruitPhase 2
- Virginia Cancer Specialists ( Site 1102), Fairfax · 11 mi ang layo
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Nagre-recruitPhase 2
- Next Virginia /ID# 279684, Fairfax · 11 mi ang layo
A Study of ASP3082 in Adults With Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi ang layo
REC-7735 in Participants With Solid Tumors
Nagre-recruitPhase 1/2
- NEXT Virginia, Fairfax · 11 mi ang layo
A Study of PHN-012 in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1
- PHN-012-001 Site, Fairfax · 11 mi ang layo
Registry Study for Radiation Therapy Outcomes
Nagre-recruitObservasyonal na pag-aaral
- Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology, Fairfax · 11 mi ang layo
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Nagre-recruitPhase 3
- Inova Schar Cancer Institute Clinical Trials, Fairfax · 11 mi ang layo
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Nagre-recruitPhase 3
- Virginia Cancer Specialists - Fairfax /ID# 280710, Fairfax · 11 mi ang layo
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Nagre-recruitPhase 2
- Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Nagre-recruitPhase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi ang layo
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Nagre-recruitPhase 1
- NEXT Virginia ( Site 0054), Fairfax · 11 mi ang layo
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Nagre-recruitPhase 1
- Investigational Site number: 404, Fairfax · 11 mi ang layo
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Nagre-recruitPhase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi ang layo
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology, Fairfax · 11 mi ang layo
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Nagre-recruitPhase 3
- USO - Virginia Cancer Specialists, Fairfax · 11 mi ang layo
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- NEXT Virginia, Fairfax · 11 mi ang layo
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Nagre-recruitPhase 1
- NEXT Oncology, Fairfax · 11 mi ang layo
Project: Every Child for Younger Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- Inova Fairfax Hospital, Falls Church · 4 mi ang layo
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
Nagre-recruitPhase 1
- NEXT Oncology Virginia, Fairfax · 11 mi ang layo
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology Virginia, Fairfax · 11 mi ang layo
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Nagre-recruitPhase 2
- 522, Fairfax · 11 mi ang layo
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Nagre-recruitPhase 1
- Virginia Cancer Specialists - Fairfax /ID# 268559, Fairfax · 11 mi ang layo
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Nagre-recruitPhase 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax · 11 mi ang layo
- Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax · 11 mi ang layo
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi ang layo
Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Nagre-recruitPhase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi ang layo
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- NEXT, Fairfax · 11 mi ang layo
Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System
Nagre-recruit
- Inova Schar Cancer - Saville Cancer Screening and Prevention Center, Fairfax · 11 mi ang layo
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Nagre-recruitPhase 1
- Research Site, Fairfax · 11 mi ang layo
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology Virginia, Fairfax · 11 mi ang layo
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT Virginia, Fairfax · 11 mi ang layo
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Nagre-recruitPhase 1/2
- NEXT Virginia, Fairfax · 11 mi ang layo
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology - Virginia, Fairfax · 11 mi ang layo
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT Virginia, Fairfax · 11 mi ang layo
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology Virginia, Fairfax · 11 mi ang layo
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- NEXT Virginia, Fairfax · 11 mi ang layo
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Nagre-recruitPhase 1/2
- NEXT Oncology, Fairfax · 11 mi ang layo
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT Virginia, Fairfax · 11 mi ang layo
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Nagre-recruitPhase 1
- NEXT Virigina, Fairfax · 11 mi ang layo
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Nagre-recruitPhase 1
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Nagre-recruitPhase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Nagre-recruitPhase 1/2
- NEXT Virginia, Fairfax · 11 mi ang layo
A Study in Patients With Advanced Cancers
Nagre-recruitPhase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi ang layo
Pag-aaral para sa Kanser (lahat ng uri) sa ibang lungsod
- Houston, TX121 pag-aaral
- New York City, NY109 pag-aaral
- Boston, MA85 pag-aaral
- Los Angeles, CA74 pag-aaral
- Nashville, TN65 pag-aaral
- Philadelphia, PA59 pag-aaral
- Washington, DC58 pag-aaral
- Durham, NC58 pag-aaral
- Chicago, IL51 pag-aaral
- Atlanta, GA49 pag-aaral
- Seattle, WA49 pag-aaral
- St. Louis, MO46 pag-aaral
Iba pang pag-aaral sa Arlington
- Non-Small Cell Lung Cancer104 pag-aaral
- Metastatic Cancer53 pag-aaral
- Colorectal Cancer52 pag-aaral
- Kanser sa Suso47 pag-aaral
- Kanser sa Ovary46 pag-aaral
- Kanser sa Baga41 pag-aaral
- Kanser ng Endometrium39 pag-aaral
- Kanser sa Pancreas33 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg26 pag-aaral
- Small Cell Lung Cancer23 pag-aaral
- Kanser sa Tiyan20 pag-aaral
- Triple-Negative Breast Cancer20 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.